We are live on ! Find out more
PAS

Point72 Asia (Singapore) Portfolio holdings

AUM $646M
1-Year Est. Return 35.24%
This Fund
S&P 500
This Quarter Est. Return
+9%
1 Year Est. Return
+35.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$379M
AUM Growth
-$153M
Cap. Flow
-$167M
Cap. Flow %
-44.21%
Top 10 Hldgs %
28.63%
Holding
1,312
New
393
Increased
138
Reduced
303
Closed
470

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$13.4M
2
NFLX icon
Netflix
NFLX
+$9.32M
3
AVGO icon
Broadcom
AVGO
+$8.2M
4
CSCO icon
Cisco
CSCO
+$7.71M
5
BAC icon
Bank of America
BAC
+$6.24M

Sector Composition

Rank Sector Weight
1 Technology 30.93%
2 Financials 16.71%
3 Healthcare 12.98%
4 Communication Services 9.13%
5 Industrials 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNW icon
501
ReNew
RNW
$2.23B
$52.3K 0.01%
+7,652
New +$46.5K
SGMO
502
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$52.2K 0.01%
51,199
-57,678
-53% -$105K
ZNTL icon
503
Zentalis Pharmaceuticals
ZNTL
$297M
$51.9K 0.01%
+17,115
New +$56.1K
WFG icon
504
West Fraser Timber
WFG
$5.58B
$51.7K 0.01%
+597
New +$55.9K
ARIS
505
DELISTED
Aris Water Solutions
ARIS
$51.5K 0.01%
+2,152
New +$46.8K
CVLT icon
506
Commault Systems
CVLT
$5.78B
$51.5K 0.01%
341
+274
+409% +$44.1K
TXG icon
507
10x Genomics
TXG
$7.44B
$51.4K 0.01%
3,578
-8,510
-70% -$134K
FNV icon
508
Franco-Nevada
FNV
$46.5B
$50.6K 0.01%
431
-919
-68% -$114K
CRBG icon
509
Corebridge Financial
CRBG
$15.4B
$50.3K 0.01%
1,681
+748
+80% +$23.1K
FDMT icon
510
4D Molecular Therapeutics
FDMT
$582M
$50.3K 0.01%
+9,025
New +$70.8K
DCO icon
511
Ducommun
DCO
$2.94B
$50K 0.01%
786
-423
-35% -$27.2K
OGS icon
512
ONE Gas
OGS
$4.96B
$49.9K 0.01%
+721
New +$52.6K
GLW icon
513
Corning
GLW
$136B
$49.5K 0.01%
1,041
-10,348
-91% -$490K
KLXE icon
514
KLX Energy Services
KLXE
$46M
$49.3K 0.01%
9,909
PMVP icon
515
PMV Pharmaceuticals
PMVP
$65.6M
$49.2K 0.01%
32,603
+413
+1% +$654
ATRA icon
516
Atara Biotherapeutics
ATRA
$77.6M
$48K 0.01%
+3,603
New +$38K
NEOV icon
517
NeoVolta
NEOV
$153M
$47.5K 0.01%
+9,116
New +$38.4K
VMEO
518
DELISTED
Vimeo
VMEO
$46.3K 0.01%
7,231
+6,522
+920% +$39.3K
EDIT icon
519
Editas Medicine
EDIT
$432M
$46.2K 0.01%
36,343
-57,446
-61% -$146K
GT icon
520
Goodyear
GT
$1.74B
$46K 0.01%
+5,111
New +$46.7K
CUBI icon
521
Customers Bancorp
CUBI
$2.78B
$45.8K 0.01%
+941
New +$47.3K
CPAY icon
522
Corpay
CPAY
$26.2B
$45.3K 0.01%
134
-830
-86% -$292K
ASTE icon
523
Astec Industries
ASTE
$991M
$45.1K 0.01%
1,343
-664
-33% -$23K
SPWH icon
524
Sportsman's Warehouse
SPWH
$46.4M
$45K 0.01%
16,856
-12,299
-42% -$30.8K
GBX icon
525
The Greenbrier Companies
GBX
$1.43B
$44.9K 0.01%
737
-1,368
-65% -$83.4K

Similar funds

Point72 Asia (Singapore)'s Q4 2024 Portfolio in Review

As of Q4 2024, Point72 Asia (Singapore) held 1,312 positions worth $379M, down 29% from $532M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Point72 Asia (Singapore) withdrew a net $167M in Q4 2024, closing 470 positions and reducing 303 holdings. Its most notable exit was NVIDIA, an estimated $34.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Point72 Asia (Singapore) opened a new position in Salesforce worth $14M.

  • Point72 Asia (Singapore)'s largest Q4 2024 buy was Salesforce: 41,861 shares worth $14M.
  • Point72 Asia (Singapore) added most to Netflix in Q4 2024, an estimated $9.32M increase.
  • Point72 Asia (Singapore)'s biggest Q4 2024 reduction was Meta Platforms (Facebook), cutting an estimated $19.9M.
  • Point72 Asia (Singapore) fully exited NVIDIA in Q4 2024, selling an estimated $34.1M.
  • Point72 Asia (Singapore)'s ten largest holdings make up 29% of its $379M portfolio in Q4 2024.
  • Point72 Asia (Singapore) opened 393 new positions and closed 470 in Q4 2024.
  • Point72 Asia (Singapore)'s portfolio value fell 29% quarter-over-quarter to $379M.

Based on Point72 Asia (Singapore)'s 13F filing for Q4 2024, filed 14 Feb 2025.